Nagler, M; Wuillemin, W (2012). [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests]. Therapeutische Umschau, 69(11), pp. 650-6. Bern: Huber 10.1024/0040-5930/a000343
Full text not available from this repository. (Request a copy)New oral anticoagulants promise to overcome essential drawbacks of traditional substances. They have a predictable therapeutic effect, a wide therapeutic window, only limited interaction with food and drugs and can be administered p.o. with a fixed dose. On the other hand, knowledge on the laboratory management of new anticoagulants is limited. In the present article we discuss possible indications and available assays for monitoring of Rivaroxaban, Apixaban and Dabigatran. Furthermore, we discuss interpretation of routine coagulation tests during therapy with these new drugs.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory |
UniBE Contributor: |
Nagler, Michael |
ISSN: |
0040-5930 |
Publisher: |
Huber |
Language: |
German |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:32 |
Last Modified: |
05 Dec 2022 14:10 |
Publisher DOI: |
10.1024/0040-5930/a000343 |
PubMed ID: |
23117668 |
URI: |
https://boris.unibe.ch/id/eprint/12591 (FactScience: 218953) |
Actions (login required)
 |
Edit item |